Stock ILMN ILLUMINA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Illumina, Inc.

Equities

ILMN

US4523271090

Advanced Medical Equipment & Technology

Market Closed - Nasdaq
Other stock markets
 01:30:00 27/04/2024 am IST 		5-day change 1st Jan Change
122.3 USD +1.02% Intraday chart for Illumina, Inc. +4.13% -12.18%
22/04 Bernstein Adjusts Price Target on Illumina to $129 From $150 MT
22/04 Baird Adjusts Price Target on Illumina to $125 From $146, Neutral Rating Kept MT

Business Summary

Illumina, Inc. specializes in the development, manufacturing and marketing of integrated systems for the analysis of genetic variation and biological function. The group's products are for genomic research centers, pharmaceutical companies, university institutions, clinical research organizations, and biotechnology companies. Net sales break down by source of income as follows:

- product sales (84.1%): tools and instruments for sequencing, genotyping, genetic expression, etc.;

- sales of services (15.9%).

Net sales are distributed geographically as follows: the United States (52.4%), Americas (3.6%), Europe (25.3%), Asia/Pacific/Middle East/Africa (10.2%) and China/Taiwan/Hong Kong (8.5%).

Number of employees: 10,615

Sales per Business

USD in Million2022Weight2023Weight Delta
Core Illumina
98.5 %
4,553 99.3 % 4,438 98.5 % -2.53%
Grail
2.1 %
55 1.2 % 93 2.1 % +69.09%
Eliminations
-0.6 %
-24 -0.5 % -27 -0.6 % +12.50%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
52.4 %
2,290 50.0 % 2,359 52.4 % +3.01%
Europe
25.3 %
-- 1,140 25.3 % -
Asia-Pacific, Middle East and Africa
10.2 %
418 9.1 % 459 10.2 % +9.81%
Greater China
8.5 %
472 10.3 % 384 8.5 % -18.64%
Americas
3.6 %
189 4.1 % 162 3.6 % -14.29%

Managers

Managers TitleAgeSince
Jacob Thaysen CEO
 Chief Executive Officer 49 25/23/25
Steven Barnard CTO
 Chief Tech/Sci/R&D Officer - 01/98/01
Carissa Rollins CTO
 Chief Tech/Sci/R&D Officer 54 14/22/14
Kevin Pegels COO
 Chief Operating Officer 57 01/21/01
Sallilyn Schwartz IRC
 Investor Relations Contact - 01/21/01
Bryan Crane PRN
 Corporate Officer/Principal - -
Scott Ericksen AUD
 Comptroller/Controller/Auditor 52 01/13/01
Bas Verhoef PRN
 Corporate Officer/Principal - 05/01
Charles Dadswell LAW
 General Counsel 65 22/13/22

Members of the board

Members of the board TitleAgeSince
Robert Epstein BRD
 Director/Board Member 69 29/12/29
Stephen MacMillan CHM
 Chairman 60 02/23/02
Caroline Dorsa BRD
 Director/Board Member 64 27/17/27
Scott Ullem BRD
 Director/Board Member 57 02/23/02
Philip Schiller BRD
 Director/Board Member 63 28/16/28
Gary Guthart BRD
 Director/Board Member 58 01/17/01
Susan Siegel BRD
 Director/Board Member 63 05/19/05
Frances Arnold BRD
 Director/Board Member 67 28/16/28
Andrew Teno BRD
 Director/Board Member 38 25/23/25
Jacob Thaysen CEO
 Chief Executive Officer 49 25/23/25

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 199,255,385 158,858,636 ( 79.73 %) 40,000,000 ( 20.07 %) 79.73 %

Shareholders

NameEquities%Valuation
Vanguard Fiduciary Trust Co.
11.44 %
18,178,513 11.44 % 2 496 M $
BlackRock Advisors LLC
6.409 %
10,183,833 6.409 % 1 398 M $
Edgewood Management LLC
4.329 %
6,878,495 4.329 % 945 M $
STATE STREET CORPORATION
4.231 %
6,723,616 4.231 % 923 M $
Baillie Gifford & Co.
3.320 %
5,275,769 3.320 % 724 M $
Loomis, Sayles & Co. LP
2.785 %
4,424,688 2.785 % 608 M $
Janus Henderson Investors US LLC
2.771 %
4,402,380 2.771 % 605 M $
Eaton Vance Management
2.327 %
3,697,580 2.327 % 508 M $
Geode Capital Management LLC
2.287 %
3,634,176 2.287 % 499 M $
WCM Investment Management LLC
2.125 %
3,377,221 2.125 % 464 M $

Company contact information

Illumina, Inc.

5200 Illumina Way

92122, San Diego

+858 202 4500

http://www.illumina.com
address Illumina, Inc.(ILMN)

Sector

Healthcare
Healthcare Services
Healthcare Equipment & Supplies
Advanced Medical Equipment & Technology
Other Advanced Medical Equipment & Technology

Sales per Business

Sales per region

Ratings for Illumina, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
122.3 USD
Average target price
157.1 USD
Spread / Average Target
+28.49%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
ILLUMINA, INC. Stock Illumina, Inc.
-12.18% 19.47B
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+8.07% 219B
DANAHER CORPORATION Stock Danaher Corporation
+6.59% 183B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+11.26% 133B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+26.57% 108B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+0.65% 63.06B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+13.35% 52.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
-0.62% 48.2B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-0.93% 40.37B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+11.54% 39.35B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. ILMN Stock
  4. Company Illumina, Inc.